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A R T I C L E S
The dysregulation of T cell responses is the cause of autoimmune disorders. T H 17 cells, a subset of CD4 + effector T cells, have a key role in the pathogenesis of many autoimmune conditions, including multiple sclerosis, an inflammatory demyelinating disease of the central nervous system (CNS), and its murine model, experimental autoimmune encephalomyelitis (EAE). Although the involvement of T cell -intrinsic pathways in T H 17 differentiation has been well described 1 , how T H 17 development is triggered by extrinsic pathways and physiological and pathological stimuli remains poorly understood.
Dendritic cells (DCs) are the most important antigen-presenting cells that bridge innate and adaptive immunity by triggering the activation and differentiation of naive T cells 2 . DCs express a repertoire of pattern-recognition receptors that sense microbial pathogen products and endogenous ligands to initiate a signaling cascade that culminates in the activation of DCs and induction of adaptive immunity. Toll-like receptors (TLRs) and downstream signaling via the adaptor Myd88 typically induce interferon-γ (IFN-γ )-producing T helper type 1 (T H 1) cells 2 . A distinct group of pattern-recognition receptors, the C-type lectin-like receptors (CLRs), are coupled to signaling via the kinase Syk and the adaptor CARD9 and ' preferentially ' polarize a T H 17 response 3, 4 . Although CLR-mediated T H 17 responses are important for protective antifungal immunity, little evidence exists for the involvement of CLR signaling in autoimmune diseases. Consequently, how the diverse innate immune signals are sensed and transduced to shape T H 17 responses and autoimmune pathogenesis remains to be established. Moreover, DCs are recruited into the CNS during EAE to reactivate primed myelin-reactive T cells, thereby propagating local inflammation and disease development during EAE 5, 6 . The function of CNS DCs is associated with their ability to mediate a T H 17-polarized response 7 , but how this process is regulated is poorly defined.
Among the central pathways activated by innate signals are those mediated by the mitogen-activated kinases (MAPKs), which include Erk, Jnk and p38 and mediate an evolutionarily conserved mechanism for cellular responses to extracellular signals 8 . Excessive activation of MAPKs is associated with autoimmune diseases, and inhibitors of these pathways have been evaluated as new therapeutic strategies 9 . Despite the rapid and reversible actions of MAPK inhibitors, their inherent nonspecific effects make such approaches unlikely to provide definitive mechanistic insights 10 . Instead, genetic delineation has been highly instrumental in elucidating the specific roles of MAPKs in the immune system. Published work has identified various functions of p38 α , the most widely expressed isoform of the p38 family, in T cell -intrinsic responses 11, 12 , including involvement in T H 17 differentiation 13 -17 . Tissue-specific deletion in macrophages and epithelial cells has also demonstrated that p38 α regulates innate responses and acute inflammation 18, 19 . However, it remains unknown whether p38 α regulates the crosstalk between innate and adaptive immunity and whether this function is important for the pathogenesis of auto immune disorders.
Here we report that p38 α acted in DCs to drive T H 17 differentiation and inflammation. We found that p38 α in DCs mediated reciprocal regulation of interleukin 6 (IL-6) and IL-27, arguably the most potent positive and negative regulators of T H 17 polarization, respectively 1, 20, 21 , and further ' imprinted ' signaling via the IL-23 receptor (IL-23R) in responding T cells. Not only was p38 α signaling in DCs essential for the induction of T H 17 differentiation, it was also required for CNS-infiltrating DCs to maintain the T H 17 population at sites of inflammation. Furthermore, in contrast to published conclusions obtained by pharmacological and dominant-negative approaches 13 -17 , we excluded the possibility of substantial involvement of T cell -intrinsic p38 signaling in T H 17 differentiation. Together our studies identify a key mechanism of DC-mediated programming of T H 17 differentiation.
RESULTS

Deletion of p38 a in DCs protects mice from EAE
Although p38 α is a chief drug target for inflammatory disorders, the specific role of p38 α in autoimmune diseases remains poorly understood. In mice that developed EAE after immunization with myelin oligodendrocyte glycoprotein peptide of amino acids 35 -55 (called simply ' MOG ' here), there was much more p38 activity in myeloid cells infiltrating the spinal cord than in CNS-resident cells ( Fig. 1a ). To determine the role of p38 in EAE, we crossed mice bearing lox P-flanked alleles encoding p38 α ( Mapk14 fl / fl ) with Rosa26-Cre-ER T2 mice (in which sequence encoding a fusion of Cre recombinase and the estrogen receptor (ER) was recombined into the ubiquitously expressed Rosa26 locus) to generate Mapk14 fl / fl Rosa26-Cre-ER T2 mice (called ' p38 α CreER mice ' here). After tamoxifen-mediated deletion of the gene encoding p38 α , we immunized mice to induce EAE. In contrast to wild-type control mice (including Cre + mice), which developed severe disease, p38 α CreER mice were completely resistant to EAE ( Fig. 1b ).
The development of EAE is dependent on multiple components of the immune system. In addition to T cells, macrophages and DCs contribute to EAE pathogenesis by functioning as antigen-presenting cells as well as effector cells to cause CNS lesions. These three cell types had much higher expression of p38 α than of the other p38 isoforms ( Supplementary Fig. 1a c ). To delineate the selective roles of p38 α in the various immune compartments, we crossed Mapk14 fl / fl mice with mice expressing Cre recombinase driven by the Cd4 promoter (CD4-Cre mice), the Lyz2 promoter (LysM-Cre mice) or the Cd11c promoter (CD11c-Cre mice) to generate p38 α Δ T , p38 α Δ Mac and p38 α Δ DC mice with deletion of p38 α in T cells, in macrophages and monocytes, and in DCs, respectively. We observed efficient deletion of p38 α in these immune compartments ( Supplementary  Fig. 1d g ). In particular, deletion of p38 α abrogated the expression and phosphorylation of p38 in DCs ( Supplementary Fig. 1h ), which indicated that the total p38 activity in DCs can be ascribed mainly to p38 α . We noticed no obvious defects in the development or homeostasis of the immune system in these mice ( Supplementary Fig. 2 and data not shown). After immunization with MOG, p38 α Δ T and p38 α Δ Mac mice had disease development similar to that of wild-type mice ( Fig. 1c,d ). In contrast, p38 α Δ DC mice had much less disease progression ( Fig. 1e ). Histological analysis showed that the CNS of p38 α Δ DC mice had significantly less inflammation and demyelination (as demonstrated by staining with hematoxylin and eosin and with Luxol fast blue, respectively), associated with fewer CD3 + T cells, npg Iba1 + macrophages and microglia, and GFAP + astrocytes ( Fig. 1f,g ). Flow cytometry analysis confirmed the diminished infiltration of CD4 + T cells and CD11b + myeloid cells into the spinal cords of p38 α Δ DC mice ( Fig. 1h ). Thus, p38 α activity in DCs was needed to precipitate the autoimmune CNS disease.
The generation of T H 17 cells in vivo requires p38 a in DCs
Although EAE has been classically considered a T H 1-dependent disease, studies have identified a key role for T H 17 cells in EAE disease development. CNS-infiltrating T cells from p38 α Δ DC mice had lower expression of Il17a mRNA (encoding IL-17A), Il17f mRNA (encoding IL-17F) and Il23r mRNA (encoding IL-23R) but normal expression of Ifng mRNA (encoding IFN-γ ), Foxp3 mRNA (encoding the transcription factor Foxp3) and Il4 mRNA (encoding IL-4) at the peak of disease than did those from wild-type mice ( Fig. 2a ). Intracellular staining showed a lower frequency of IL-17 + CD4 + T cells in CNS of p38 α Δ DC mice than in CNS of wild-type mice, whereas the frequency of IFN-γ + and Foxp3 + CD4 + T cells was similar in the two groups of mice ( Fig. 2b ).
To determine whether the diminished generation of T H 17 cells was secondary to attenuated CNS inflammation, we analyzed T cell responses in the draining lymph nodes at the preclinical stage of EAE (day 7 after immunization). T cells from p38 α Δ DC mice proliferated normally after ex vivo stimulation with MOG (data not shown) but were deficient in IL-17 secretion ( Fig. 2c ). Also, there was a lower frequency of IL-17 + cells among the CD4 + T cells that had proliferated in response to stimulation with MOG (cells with low abundance of the cytosolic dye CSFE) in immunized p38 α Δ DC mice than in immunized wild-type mice ( Fig. 2d ). These results identified a key role for p38 α in DCs in the promotion of MOG-induced T H 17 responses in vivo .
To determine if the requirement for DC-derived p38 α signals was restricted to MOG-induced responses, we immunized wild-type and p38 α Δ DC mice with the protein antigen keyhole limpet hemocyanin. Draining lymph node cells from p38 α Δ DC mice had no defects in proliferation (data not shown) but had lower IL-17 expression in the recall response ( Fig. 2e ). We also examined the IL-17 + CD4 + T cells in gut-associated lymphoid tissues known to contain a sizable population of T H 17 cells in response to commensal microbiota 22 . CD4 + T cells from p38 α Δ DC mice included a significantly lower frequency of IL-17 + cells but a normal frequency of IFN-γ + cells ( Fig. 2f ). We conclude that p38 α signaling in DCs is crucial for promoting the development of T H 17 responses in vivo .
DCs depend on p38 a to drive T cell expression of IL-17 and IL-23R
The results reported above prompted us to assess whether p38 α mediates DC -T cell crosstalk by driving the lineage differentiation of antigen-specific naive precursors. For this, we transferred naive T cells (CD62L hi CD44 lo and Thy-1.1 + ) from 2D2 mice (with transgenic expression of a T cell antigen receptor (TCR) specific for MOG) 23 into wild-type and p38 α Δ DC mice, followed by immunization with cognate antigen emulsified in complete Freund ' s adjuvant (CFA). Donor T cells isolated from p38 α Δ DC hosts included fewer IL-17 + cells and had lower Il17a mRNA expression in the recall response relative to those isolated from wild-type mice, whereas IFN-γ expression was unaltered ( Fig. 3a,b ). We further used T cells from a second TCR-transgenic model, OT-II mice, which have transgenic expression of a TCR specific for ovalbumin amino acids 323 -339 (called simply ' OVA ' here). There was less development of donor T cells into T H 17 cells in p38 α Δ DC hosts than in wild-type hosts in response to immunization with OVA in the presence of CFA Fig. 3 ). Therefore, deletion of p38 α in DCs impaired the differentiation of antigen-specific T H 17 cells in vivo . We next cultured naive OT-II T cells together with splenic DCs in the presence of antigen and lipopolysaccharide (LPS), but without any exogenous cytokines, to model the physiological interaction between DCs and T cells. T cells stimulated with p38 α Δ DC DCs developed into a significantly lower frequency of IL-17 + cells than did those stimulated with wild-type DCs ( Fig. 3d ). This was associated with lower Il17a mRNA expression ( Fig. 3e ) and impaired upregulation of the chemokine receptor CCR6, a selective surface marker for T H 17 cells, but not of the T H 1-specific receptor CXCR3 ( Supplementary Fig. 4a ). We observed a similar defect when we used a synthetic ligand for TLR2 instead of LPS ( Supplementary Fig. 4b,c ). Notably, we observed less T H 17 differentiation in various DC subsets lacking p38 α , with the CD11b + DC subset showing a greater defect ( Fig. 3f ). We noticed that IFN-γ expression in OVA-specific T cells was modestly upregulated by incubation with p38 α Δ DC DCs in vitro ( Fig. 3df ). To determine whether the defective T H 17 differentiation was due to IFN-γ upregulation, we added a neutralizing antibody to IFN-γ (anti-IFN-γ ). This resulted in the expected overall higher IL-17 expression, but T cells stimulated with p38 α Δ DC DCs remained deficient in T H 17 differentiation ( Fig. 3g ). Moreover, we also observed less IL-17 expression in IFN-γ -deficient T cells activated with p38 α Δ DC DCs than in those activated with wild-type DCs ( Fig. 3h ), which excluded the possibility of a contribution from IFN-γ production to the p38 α -dependent T H 17 differentiation. Thus, p38 α has a direct role in mediating DC -T cell crosstalk for T H 17 differentiation.
We npg and IL-7R α expression (important for the population expansion of T H 17 cells 24 ) of T cells were undisturbed in T cells cultured with p38 α Δ DC DCs (data not shown). We examined the expression of T H 17-associated factors by real-time PCR analysis of DC-activated T cells. T cells cultured with p38 α Δ DC DCs had much lower expression of genes encoding cytokines produced by T H 17 cells (including Il17a , Il17f , Il21 and Il22 ) and genes encoding the transcription factors ROR γ t ( Rorc ) and ROR α ( Rora ) during the differentiation process than did those cultured with wild-type DCs ( Fig. 3i ). The development of T H 17 cells requires IL-23R, which is induced by T H 17-polarizing cytokines and confers enhanced responsiveness to IL-23 to facilitate the terminal differentiation and population expansion of T H 17 cells 25 -27 . T cells activated with p38 α Δ DC DCs were impaired in the induction of Il23r expression, whereas expression of genes encoding other receptor chains (including Il12rb1 , Il12rb2 and Il6ra ) was unaltered ( Fig. 3j ). To examine the role of IL-23R in mediating DC-dependent T H 17 responses, we first used an IL-23Rblocking antibody and found that it diminished IL-17 expression in a dose-dependent manner in T cells stimulated with wild-type DCs ( Supplementary Fig. 5 ). To further determine whether the lower induction of IL-23R contributed to the T H 17 phenotype mediated by p38 α Δ DC DCs, we introduced IL-23R into T cells by retroviral transduction. Overexpression of IL-23R resulted in higher Il17a expression in T cells activated with either wild-type or p38 α Δ DC DCs than in cells transduced with control virus; however, the difference between wild-type and p38 α Δ DC DCs became less pronounced ( Fig. 3k ). These results indicated that the induction of IL-23R expression in responding T cells is an important mechanism by which p38 α mediates the DC -T cell crosstalk, although additional mechanisms are probably involved.
Effect of p38 a on the expression of IL-6, IL-27 and CD86 in DCs
We explored the cellular mechanisms by which p38 α acts in DCs to regulate T H 17 differentiation. To determine whether p38 α regulates DC cytokine expression, we isolated DCs from mice after immunization with MOG. Among genes encoding cytokines known to npg potentiate T H 17 differentiation, there was selectively lower Il6 expression in splenic DCs from p38 α Δ DC mice than in those from wild-type mice after immunization ( Fig. 4a ). We also observed this selectively lower abundance of IL-6 in p38 α Δ DC DCs after in vivo or in vitro stimulation with LPS ( Fig. 4b,c ). Accordingly, phosphorylation of the transcription factor STAT3 but not of STAT4 was lower in T cells activated with p38 α Δ DC DCs than in those activated with wild-type DCs ( Fig. 4d ). Therefore, p38 α activated the IL-6 -STAT3 axis at the DC -T cell interface.
We assessed the functional importance of p38 α -dependent IL-6 expression. Similar to p38 α -deficient DCs, IL-6-deficient DCs had an impaired ability to drive the expression of Il17a and Il23r in T cells ( Supplementary Fig. 6a ). The addition of IL-6 to p38 α Δ DC DCs nearly completely restored the defective Il23r expression in T cells ( Fig. 4e ) and resulted in a greater frequency of IL-17 + cells among cocultured T cells, although the restoration of IL-17 expression was incomplete ( Fig. 4f ). DCs deficient in both IL-6 and p38 α had an attenuated ability to induce Il17a expression than did IL-6-deficient DCs ( Supplementary Fig. 6b ). Therefore, p38 α -dependent IL-6 expression in DCs mediated the generation of T H 17 cells, although additional mechanisms seemed to contribute as well.
T H 17 differentiation is shaped by both positive and negative polarizing cytokines. IL-27 is a potent cytokine that limits T H 17 differentiation 20, 21 ; its expression can be repressed by osteopontin (encoded by Spp1 ) in DCs 28, 29 . After MOG immunization, Il27 expression was higher and Spp1 expression was lower in p38 α -deficient DCs than in wild-type cells ( Fig. 4g ). Although IL-27 can activate many STAT proteins, blocking IL-27 substantially restored the defective STAT3 activation in T cells stimulated with p38 α Δ DC DCs ( Fig. 4h ), consistent with the contrasting effects of IL-27 and IL-6 on T H 17 development 20, 21 . Furthermore, whereas exogenous IL-6 and blockade of IL-27 each had a modest effect on the promotion of Il17a expression mediated by p38 α Δ DC DCs, a combination of both considerably restored T H 17 differentiation ( Fig. 4i ). In addition to affecting cytokine production, p38 α was required for LPS-induced expression of the DC costimulatory molecule CD86 but not of the costimulatory molecule CD80 ( Fig. 4j ). Blocking CD86 function in wild-type DCs diminished T H 17 differentiation but did not substantially affect IFN-γ production ( Fig. 4k and Supplementary Fig. 7 ), in agreement with a role for CD86 in T H 17 responses 30, 31 . Collectively, these data showed that p38 α exerted opposing effects on the positive and negative regulators of T H 17 generation and further shaped the strength of the costimulatory signals, thereby orchestrating a program for DC-dependent T H 17 differentiation. of dectin-1, a CLR that recognizes β -glucans) had stronger in vivo adjuvant activity than LPS in the T H 17 response ( Fig. 5a ) and induced more upregulation of p38 activity in DCs than did LPS ( Fig. 5b ). Deficiency of p38 α in DCs diminished the T H 17 differentiation mediated by either LPS or curdlan, with a greater effect on curdlan-induced differentiation ( Fig. 5a ). After being stimulated with curdlan in vivo , antigen-specific donor T cells from p38 α Δ DC hosts had lower expression of Il17a , Il17f , Il21 , Il22 , Rorc and Il23r ( Fig. 5c ), which indicated that p38 α mediated CLR-induced T H 17differentiation signals in DCs. We further compared the effects of various pathogens on p38 activation in DCs and T H 17 differentiation. Prototypic bacteria such as the Gram-positive Listeria monocytogenes and Gram-negative Legionella pneumophila are known to induce strong T H 1-polarized responses, whereas fungi (including Candida albicans and Saccharomyces cerevisiae ) seem to be the most potent pathogens characterized as eliciting T H 17 responses 33 . When we used heat-killed bacteria and fungi (to avoid variation due to differences in pathogen clearance) as adjuvants to stimulate antigen-specific T cells in vivo , we found that C. albicans and S. cerevisiae generated a much greater T H 17 response than L. monocytogenes or L. pneumophila did ( Fig. 5d ). This was associated with the ability of C. albicans and S. cerevisiae to strongly activate p38 in DCs ( Fig. 5e ). Notably, splenocytes from p38 α Δ DC mice infected with live C. albicans produced less IL-17 than did those from infected wild-type mice, whereas IFN-γ expression was normal ( Fig. 5f ). Thus, fungal stimulation represents a robust activator of p38 in DCs for the induction of T H 17 responses.
DCs integrate T H 17-instructive signals via p38 a
In agreement with reports suggesting that activation of the costimulatory molecule CD40 and its ligand CD40L can promote T H 17 differentiation 34, 35 , we detected defective T H 17 differentiation induced by CD40-deficient DCs ( Supplementary Fig. 8a ). Notably, anti-CD40 strongly upregulated p38 activity in DCs ( Supplementary Fig. 8b ) , and p38 α deficiency in DCs diminished T H 17 differentiation after stimulation with anti-CD40 ( Supplementary Fig. 8c ). We conclude that p38 α is a convergent point in DCs for the integration of infectious and inflammatory signals to ' instruct ' T H 17 differentiation.
Effector pathways dependent on p38 a in DC signal integration
We investigated p38 α -dependent effector pathways that could mediate the diverse upstream inputs noted above. Deficiency in p38 α led to less IL-6 production by DCs stimulated with curdlan or anti-CD40 in vivo ( Fig. 6a,b ) and in vitro ( Fig. 6c ), whereas the production of IL-1 β and transforming growth factor-β 1 was not altered. DC expression of Il27 and Spp1 was also affected by p38 α deficiency after stimulation with LPS and curdlan, whereas their expression was independent of p38 α in response to anti-CD40 ( Supplementary Fig. 9 ). These results indicated that IL-6 is a shared target of p38 α in DCs activated with different stimuli.
To examine the signaling and transcriptional pathways involved in IL-6 expression, we assessed activation of MK2 and MSK1 (two known p38 targets) 8 and noted that it was lower in LPS-stimulated p38 α Δ DC DCs than in LPS-stimulated wild-type cells ( Fig. 6d ). Additionally, activation of two transcription factors important for IL-6 production, CREB and c-Fos 36 , was lower, whereas phosphorylation of the transcription factor C / EBP β and the inhibitor I κ B α (indicative of transcription factor NF-κ B activity) was not affected (Fig. 6d and  Supplementary Fig. 10 ). Activation of MK2, MSK1, CREB and c-Fos was similarly lower in p38 α -deficient DCs after stimulation with curdlan or anti-CD40 than in simulated wild-type DCs ( Fig. 6e ), which indicated that a core set of molecular targets was activated by p38 α in response to diverse upstream inputs. Furthermore, relative to results obtained by treatment with vehicle control, treatment of wild-type DCs with an MK2 inhibitor resulted in less IL-6 production after stimulation with LPS, curdlan or anti-CD40 ( Fig. 6f ) and less ability npg to drive T H 17 generation after stimulation with LPS ( Fig. 6g,h ), curdlan or anti-CD40 (data not shown). Finally, p38 α and MK2 were also required for IL-6 production in DCs after stimulation with heat-killed C. albicans ( Supplementary Fig. 11 ). These results collectively established that a p38 α -MK2 signaling axis integrated upstream signals in DCs for T H 17 differentiation.
Effects of p38 a in CNS DCs and therapeutic targeting
During EAE, DCs are recruited into the CNS, where they present antigens to myelin-specific T cells and polarize the local T H 17 response 5, 7 .
To determine if CNS DCs require p38 α to actively maintain the proinflammatory T H 17 response, we immunized p38 α CreER mice with MOG and began tamoxifen treatment at day 7 to bypass the requirement for p38 α in T cell priming in the periphery. Such treatment resulted in considerable amelioration of disease severity ( Fig. 7a ) and inflammation and demyelination of CNS ( Fig. 7b ). DCs isolated from CNS after acute deletion of p38 α were impaired in the induction of Il17a expression and Il23r expression from cocultured 2D2 T cells in vitro ( Fig. 7c ), which indicated a key function for p38 α in CNS DCs for mediating T H 17 responses. Using a model of EAE involving the transfer of T H 17-polarized cells 37 , we next investigated the contribution of p38 α in DCs to the effector phase of CNS inflammation. After adoptive transfer of T H 17 effector cells into recipient mice, wild-type recipients rapidly developed EAE, whereas p38 α Δ DC mice showed delayed onset and less disease severity ( Fig. 7d ). Expression of Il17a mRNA and Il23r mRNA was lower in CNS-infiltrating cells from p38 α Δ DC mice than in those from wild-type mice ( Fig. 7e ) . These results suggested a continuous requirement for p38 α activity in DCs for sustaining IL-23R expression and T H 17 responses at sites of inflammation.
To further evaluate the role of p38 α in DCs as a therapeutic target for T H 17-mediated diseases, we investigated if these regulatory pathways applied to human cells as well. We treated DCs derived from human peripheral blood monocytes with a p38 inhibitor and then cultured them with naive T cells. As with the mouse DCs used as control ( Fig. 7f ), blocking p38 in human DCs diminished IL-17 expression from T cells ( Fig. 7g,h ) , as well as IL-6 production from DCs ( Fig. 7i ). Thus, p38 activity represents an evolutionarily conserved pathway that shapes DC-dependent T H 17 differentiation.
T H 17 differentiation does not require p38 in T cells
Published studies have suggested an important role for p38 in T cells for the generation of T H 17 cells 13 -17 . Although deletion of p38 α in T cells did not protect mice from EAE ( Fig. 1c ), we further tested whether p38 regulates T H 17 differentiation in a T cell -intrinsic manner. Naive T cells from p38 α Δ T mice differentiated normally into T H 17 cells under in vitro polarizing conditions ( Fig. 8a,b ), despite the loss of p38 expression and phosphorylation in these cells ( Supplementary Fig. 12a ). To exclude the possibility of compensation from other members of the p38 family, we generated mice lacking both the p38 α and p38 β isoforms (called ' p38 α Δ T p38 β KO mice ' here), because these two p38 isoforms are detectable in T cells ( Supplementary Fig. 1a ). T H 17 differentiation in vitro was normal in T cells from p38 α Δ T p38 β KO mice ( Fig. 8c,d ). In addition, immunization of wild-type, p38 α Δ T , p38 β KO and p38 α Δ T p38 β KO mice with MOG peptide followed by ex vivo recall response to antigen or polyclonal stimulation demonstrated similar IL-17 expression in T cells ( Fig. 8e and Supplementary Fig. 12b ). In addition, the transfer of naive T cells from p38 α Δ T p38 β KO OT-II mice into wild-type mice followed by OVA immunization showed that T cells lacking p38 α and npg p38 β were as efficient as wild-type cells in producing IL-17 ( Fig. 8f ). Together our results exclude the possibility of a T cell -intrinsic function for p38 signaling in T H 17 differentiation.
DISCUSSION
How instructive signals derived from the innate immune system trigger T H 17 responses and inflammation, in contrast to T cell -intrinsic transcriptional mechanisms 1 , remains poorly understood. Here we have reported that p38 α integrated a diverse array of immunostimulatory signals in DCs to direct the generation of T H 17 cells under autoimmune, inflammatory and infectious conditions, thereby establishing a previously unappreciated pathway of DC-dependent programming of T H 17 differentiation. We found that p38 α directed the production of IL-6 and IL-27 and further shaped CD86 expression in DCs and ' imprinted ' STAT3 signaling and IL-23R expression in responding T cells. Although p38 α deficiency in DCs did not completely abrogate DC-dependent IL-17 production by T cells, this pathway had a critical role in disease pathogenesis and may represent a likely therapeutic target, as both the induction and effector phases of autoimmune inflammation were very much dependent on p38 α activity in DCs.
Adaptive immunity is controlled by DC-derived signals at multiple checkpoints that dictate the activation and differentiation of T cell -mediated immune responses 2 . The few innate immune pathways identified as potentiating the T H 17 response, such as dectin-Syk -CARD9 signaling 3, 4 , transduce a specific type of pathogen-derived signals. In addition, their involvement in autoimmune diseases is unclear. Additional DC signaling pathways, such as MKP-1 and Wnt -β -catenin signaling, have been shown to downregulate T H 17 differentiation, although they also influence many other T cell lineages 32, 38 . Here we have shown that p38 α was potently activated in DCs by T H 17instructive innate signals via engagement of pattern-recognition receptors, as well as T cell -dependent CD40 signals, to induce IL-6 production. Moreover, p38 α regulated IL-27 downstream of innate signals (TLRs and CLRs) but not adaptive signals (CD40) and further shaped costimulatory signals. Thus, p38 α orchestrates a program for DC-dependent T H 17 differentiation under inflammatory conditions, although its role in the steady state requires additional analysis.
DCs are sparse in the healthy CNS but become much more abundant during CNS inflammation. Whereas CNS DCs have been linked to the driving of T H 17 responses and precipitation of inflammation 5 -7 , opposing evidence also exists 39, 40 . Among distinct subsets of DCs, CD11b + myeloid DCs are most efficient at driving T H 17 differentiation in the CNS 7 . Consistent with that observation, we found that CD11b + DCs were more dependent on p38 α activity for directing T H 17 differentiation than were CD8 + DCs. By identifying a molecular pathway in CNS DCs that drove T H 17 responses and disease pathogenesis, our findings have provided critical genetic evidence supporting the idea of a key proinflammatory function for CNS DCs in vivo .
Studies have shown that p38 acts in a T cell -intrinsic manner for T H 17 development, as IL-17 expression is diminished after pharmacological inhibition of p38 or expression of a dominant-negative p38 transgene 13 -17 . However, by T cell -specific deletion of p38 α in multiple in vitro and in vivo systems, and after excluding the possibility of functional redundancy between the two p38 isoforms expressed by T cells (p38 α and p38 β ), we found no evidence of a T cell -intrinsic function for p38 in T H 17 responses. The function of p38 described before in T cells could have resulted from nonspecific effects of the experimental approaches or the inability to distinguish the effects in T cells from those in antigen-presenting cells. Our results support the proposal of a selective role for p38 α in DC-mediated T H 17 differentiation but not in T cell -intrinsic T H 17 differentiation, although our results have not excluded the possibility of a function for p38 in T cells under other conditions 11, 12 . Moreover, p38 α activity in other cell types also contributes to EAE, as systemic ablation of p38 α resulted in complete protection from EAE but DC-specific deletion of p38 α did not.
Among protein kinase targets for the development of anti-inflammatory drugs in the pharmaceutical industry, p38 α is by far the most extensively investigated, but severe side effects have prevented the clinical advancement of p38 α inhibitors 9 . Our findings have potential implications for use of the vast number of p38 α inhibitors already available. First, our results have indicated that p38 α inhibitors would be effective for T H 17-mediated diseases. Heterogeneity in T cell effector responses is a common feature of autoimmune diseases, and both T H 17 and T H 1 responses can mediate multiple sclerosis and EAE. Notably, IFN-β , the most frequently prescribed therapy for relapsing-remitting multiple sclerosis, is ineffective in 30 -50 % patients with a prevalent T H 17 response 41 . Second, our results have suggested that selective targeting of DCs is sufficient for therapeutic efficacy, and the use of new drug-delivery vehicles to target p38 α inhibitors to specific tissues or cell types is a promising strategy for avoiding undesired side effects 42 . Therefore, p38 α -dependent regulation of DC functions and T H 17 responses can be further explored for innovative autoimmune therapies.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
